CIK 0001703057 · Large accelerated filer
AbCellera Biologics Inc.
Sign in to watch- Ticker
- ABCL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 559-9005
- Business address
- 150 W 4TH AVENUE, VANCOUVER, British Columbia, Canada, V5Y 1G6
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Gift 10% owner gave 225,000 shares (gift)
- 4 Open-market buy Director bought 50,000 shares at $3.57 ($178,460)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 343,631 shares at $2.16 ($742,243)
- 4 Open-market buy Director bought 25,000 shares at $2.30 ($57,500)
- 4 Open-market buy Director bought 60,000 shares at $2.34 ($140,568)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Gift 10% owner gave 286,000 shares (gift)
- 4 Option exercise Chief Executive Officer acquired 56,125 shares (option exercise)
Page 2 of 8 · 145 filings